Dec. 16 at 5:27 PM
$FBIO $FBIOP Need to clarify the remaining "129m in development / milestone payments"
Approval Deadline reductions of all below values apply, since Sentynl took over from Sept. 30, 2023.
The Approval Deadline Reduction is 50%.
FDA Acceptance triggers 9m "Purchase Price"
(a) Five Million Dollars (
$5,000,000), within thirty (30) days of achieving Net Sales of Seventy-Five Million Dollars (
$75,000,000) during any Commercialization Year;
(b)Twenty-Five Million Dollars (
$25,000,000), within thirty (30) days of achieving Net Sales of One Hundred Twenty-Five Million Dollars (
$125,000,000) during any Commercialization Year;
(c)Thirty-Five Million Dollars (
$35,000,000), within thirty (30) days of achieving Net Sales of One Hundred Seventy-Five Million Dollars (
$175,000,000) during any Commercialization Year;
(d)Forty Million Dollars (
$40,000,000), within thirty (30) days of achieving Net Sales of Two Hundred Million Dollars (
$200,000,000) during any Commercialization Year;
...cont. (1/2)
